These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32828220)

  • 21. Assessing the financial, operational, and social sustainability of a biobank: the Wales Cancer Bank case study.
    Parry-Jones A
    Biopreserv Biobank; 2014 Dec; 12(6):381-8. PubMed ID: 25496149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nottingham Health Science Biobank: a sustainable bioresource.
    Matharoo-Ball B; Thomson BJ
    Biopreserv Biobank; 2014 Oct; 12(5):312-6. PubMed ID: 25340939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Plan for Academic Biobank Solvency-Leveraging Resources and Applying Business Processes to Improve Sustainability.
    Uzarski D; Burke J; Turner B; Vroom J; Short N
    Clin Transl Sci; 2015 Oct; 8(5):553-7. PubMed ID: 25996355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The EuPA Biobank Initiative: Meeting the future challenges of biobanking in proteomics & systems medicine.
    Wheelock ÅM; Paulson L; Litton JE;
    J Proteomics; 2015 Sep; 127(Pt B):414-6. PubMed ID: 26216594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Business Planning for a Campus-Wide Biobank.
    Tarling TE; Lasser F; Carter C; Matzke LA; Dhugga G; Arora N; Dee S; LeBlanc J; Babinsky S; O'Donoghue S; Cheah S; Watson P; Vercauteren SM
    Biopreserv Biobank; 2017 Feb; 15(1):37-45. PubMed ID: 28151006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Legacy samples in Finnish biobanks: social and legal issues related to the transfer of old sample collections into biobanks.
    Salokannel M; Tarkkala H; Snell K
    Hum Genet; 2019 Dec; 138(11-12):1287-1299. PubMed ID: 31620872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Market-driven production of biospecimens and the role of NHS hospital-led biobanks.
    Timmons S; Vezyridis P
    Sociol Health Illn; 2017 Sep; 39(7):1242-1257. PubMed ID: 28555937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The biological resources and molecule archives organization: turn a need into an opportunity for the Smart Specialization Strategy of the Lazio region.].
    Bravo E; Franchin T; Santoro F; Conti L; Carrara S; Marino M; Di Caro A; Cigliana G; Mandoj C; Baselice S; Daniele N; Giampaoli S; Quintarelli C; Salerno M; Zinno F; Russo G; Errico MC; Minghetti L; Ricciardi W; Napolitano M
    Recenti Prog Med; 2019 Feb; 110(2):68-74. PubMed ID: 30843531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Experience with establishment and operation of a biobank].
    Stege A; Hummel M
    Pathologe; 2008 Nov; 29 Suppl 2():214-7. PubMed ID: 18712392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishing an academic biobank in a resource-challenged environment.
    Soo CC; Mukomana F; Hazelhurst S; Ramsay M
    S Afr Med J; 2017 May; 107(6):486-492. PubMed ID: 28604319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The implementation of a Biobank network for Chile].
    Ríos JA; Alcalde E; Ramírez E; Campbell M; Labbé TP; Becerra S; Santander S; Cabrera ME
    Rev Med Chil; 2019 Jul; 147(7):901-909. PubMed ID: 31859989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges for the Sustainability of University-Run Biobanks.
    Kongsholm NCH; Christensen ST; Hermann JR; Larsen LA; Minssen T; Pedersen LB; Rajam N; Tommerup N; Tupasela A; Schovsbo J
    Biopreserv Biobank; 2018 Aug; 16(4):312-321. PubMed ID: 30016130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Challenges and Driving Forces for Business Plans in Biobanking.
    Macheiner T; Huppertz B; Bayer M; Sargsyan K
    Biopreserv Biobank; 2017 Apr; 15(2):121-125. PubMed ID: 28338345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Research Perspective on Utilizing and Valuing Tumor Biobanks.
    Rush A; Matzke L; Cooper S; Gedye C; Byrne JA; Watson PH
    Biopreserv Biobank; 2019 Jun; 17(3):219-229. PubMed ID: 30575428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transformation of the Taiwan Biobank 3.0: vertical and horizontal integration.
    Lin JC; Hsiao WW; Fan CT
    J Transl Med; 2020 Aug; 18(1):304. PubMed ID: 32762757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Future of Biobanking: A Conceptual Look at How Biobanks Can Respond to the Growing Human Biospecimen Needs of Researchers.
    Somiari SB; Somiari RI
    Adv Exp Med Biol; 2015; 864():11-27. PubMed ID: 26420610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Business Planning in Biobanking: How to Implement a Tool for Sustainability.
    Ciaburri M; Napolitano M; Bravo E
    Biopreserv Biobank; 2017 Feb; 15(1):46-56. PubMed ID: 27898226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Significance of Biobanking in the Sustainability of Biomedical Research: A Review.
    Zohouri M; Ghaderi A
    Iran Biomed J; 2020 Jul; 24(4):206-13. PubMed ID: 32306718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uppsala Biobank-the development of a biobank organization in a local, regional, and national setting.
    Beskow A
    Ups J Med Sci; 2019 Jan; 124(1):6-8. PubMed ID: 30706759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usage Data and Scientific Impact of the Prospectively Established Fluid Bioresources at the Hospital-Based MedUni Wien Biobank.
    Haslacher H; Gerner M; Hofer P; Jurkowitsch A; Hainfellner J; Kain R; Wagner OF; Perkmann T
    Biopreserv Biobank; 2018 Dec; 16(6):477-482. PubMed ID: 30335475
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.